Atea Pharmaceuticals, Inc.

NASDAQ:AVIR

Biotechnology

Healthcare
$3.99 -0.81%

-$0.04 today

Market cap
$320.41M
Beta
0.32
P/E (TTM)
-2.0
EPS (TTM)
-$2.14
52W Low $2.78High $6.45

Volume 0.34M

Average 0.34M

Balance Sheet

Inspect the capital base behind the business.

Assets

$315.22M

FY 2025 · Annual

-32.2% YoY

Liabilities

$39.78M

FY 2025 · Annual

+54.2% YoY

Equity

$275.43M

FY 2025 · Annual

-37.2% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents764.38M646.71M143.82M64.7M95.71M
Short-term Investments00434.28M390.03M206.12M
Net Receivables00000
Inventory00000
Other Current Assets(0)14.21M12.35M7.63M9.16M
Total Current Assets772.4M660.92M590.46M462.36M310.99M
Property, Plant & Equipment (Net)184K4.09M3.12M2.12M1.09M
Goodwill00000
Intangible Assets00000
Long-term Investments305K198K000
Tax Assets00000
Other Non-current Assets01.49M1.4M197K3.14M
Total Non-current Assets489K5.79M4.51M2.31M4.23M
Total Assets772.89M666.71M594.97M464.67M315.22M
Account Payables4.53M2.55M4.25M4.46M12.95M
Short-term Debt0000843K
Tax Payables099K000
Deferred Revenue00000
Other Current Liabilities27.57M8.65M07.44M19.56M
Total Current Liabilities56.88M18.48M32.38M18.6M39.78M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities5.93M5.26M5.76M6.36M0
Total Non-current Liabilities5.93M7.66M7.4M7.2M0
Total Liabilities62.82M26.14M39.78M25.8M39.78M
Common Stock83K83K83K84K78K
Retained Earnings56.03M(59.88M)(195.84M)(364.22M)(522.57M)
Accumulated OCI(0)(684K)207K233K174K
Other Stockholders Equity00000
Minority Interest00000
Total Equity710.08M640.57M555.19M438.87M275.43M
Total Debt197K3.12M2.4M1.64M843K
Net Debt(764.18M)(643.59M)(141.42M)(63.05M)(94.87M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$79.3M
Short-term Investments$176.7M
Other Current$7.2M
Total Current Assets$263.2M
PP&E (Net)$831.0K
Other Non-current$3.0M
Total Non-current Assets$3.9M
Total Assets$267.1M

Analysis

Selected assets total $267.1M for Latest. The largest visible component is Short-term Investments at $176.7M, about 66.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 9, 2026
8-KCurrent reportNov 9, 2026
SC 13GSC 13G filingOct 6, 2026

How much cash does AVIR have?

Atea Pharmaceuticals, Inc. (AVIR) reported $95.71M in cash and equivalents in fiscal 2025.

How much debt does AVIR carry?

Atea Pharmaceuticals, Inc. (AVIR) reported $843,000.00 of total debt, with net debt of -$94.87M.